Indigenous Vaccine Against Dengue

Context: 

Indian drugmakers Serum Institute of India and Panacea Biotec have submitted their responses to the Indian Council of Medical Research (ICMR) for an Expression of Interest (EOI) to collaborate on Phase 3 clinical trials for India’s first dengue vaccine. 

About Dengue:

• Dengue (break-bone fever) is a viral infection caused by dengue virus (DENV) that spreads from mosquitoes to people. 
• It is more common in tropical and subtropical climates.
• Symptoms: High fever, Severe headache, Pain behind the eye, Muscle and joint pains, Nausea.
• Treatment: There is no specific treatment for dengue. 
• The ICMR says the den­gue viral disease causes significant morbidity and mortality across the globe and in India, 2 to 2.5 lakh cases are reported annually.
• In 2019, the World Health Organization (WHO) identified dengue to be one among the top 10 global health threats.

News Source: The Hindu

DOWNLOAD PDF